Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company developing antiviral therapies targeting respiratory viral diseases like influenza and COVID-19. Its key products include investigational agents such as tivoxavir marboxil and ratutrelvir. The company focuses on innovative, safe, and simple-dose treatments, leveraging accelerated clinical strategies to address unmet medical needs in infectious diseases and cancer, with a global licensing and partnership approach.
This description was generated via AI from an annual report. Updated about 1 year ago.